1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827764707455401984 |
|---|---|
| author | Martin Gutierrez Deborah Glass Jee Hyun Park Tania Felizardo Daniel H Fowler |
| author_facet | Martin Gutierrez Deborah Glass Jee Hyun Park Tania Felizardo Daniel H Fowler |
| author_sort | Martin Gutierrez |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:09:12Z |
| format | Article |
| id | doaj.art-24fad4c433af419ebc12c9091f6892ab |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:09:12Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-24fad4c433af419ebc12c9091f6892ab2023-11-12T07:15:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.10281028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioningMartin Gutierrez0Deborah Glass1Jee Hyun Park2Tania Felizardo3Daniel H Fowler46Hackensack University Medical Center, -, Hackensack, USAMonash University, Melbourne, Australia1Rapa Therapeutics, Rockville, MD, USA1Rapa Therapeutics, Rockville, MD, USA1Rapa Therapeutics, Rockville, MD, USA |
| spellingShingle | Martin Gutierrez Deborah Glass Jee Hyun Park Tania Felizardo Daniel H Fowler 1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning Journal for ImmunoTherapy of Cancer |
| title | 1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning |
| title_full | 1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning |
| title_fullStr | 1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning |
| title_full_unstemmed | 1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning |
| title_short | 1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning |
| title_sort | 1028 ex vivo chemotherapy resistance of metabolically reprogrammed autologous th1 tc1 cells rapa 201 towards the clinical translation of immune sparing host conditioning |
| work_keys_str_mv | AT martingutierrez 1028exvivochemotherapyresistanceofmetabolicallyreprogrammedautologousth1tc1cellsrapa201towardstheclinicaltranslationofimmunesparinghostconditioning AT deborahglass 1028exvivochemotherapyresistanceofmetabolicallyreprogrammedautologousth1tc1cellsrapa201towardstheclinicaltranslationofimmunesparinghostconditioning AT jeehyunpark 1028exvivochemotherapyresistanceofmetabolicallyreprogrammedautologousth1tc1cellsrapa201towardstheclinicaltranslationofimmunesparinghostconditioning AT taniafelizardo 1028exvivochemotherapyresistanceofmetabolicallyreprogrammedautologousth1tc1cellsrapa201towardstheclinicaltranslationofimmunesparinghostconditioning AT danielhfowler 1028exvivochemotherapyresistanceofmetabolicallyreprogrammedautologousth1tc1cellsrapa201towardstheclinicaltranslationofimmunesparinghostconditioning |